Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Erik Lagolio"'
Autor:
Davide Roberto Donno, Ignazio Grattagliano, Alessandro Rossi, Pierangelo Lora Aprile, Gerardo Medea, Erik Lagolio, Guido Granata, Nicola Petrosillo, Claudio Cricelli
Publikováno v:
Infectious Disease Reports, Vol 13, Iss 1, Pp 251-258 (2021)
The impact of the coronavirus disease (COVID-19), caused by the novel coronavirus SARS-CoV-2, continues to be widespread, with more than 100 million cases diagnosed in more than 220 countries since the virus was first identified in January 2020. Alth
Externí odkaz:
https://doaj.org/article/11dce70f805242f3b9fd9b791aad6b47
Autor:
Stefano Celotto, Nicola Veronese, Mario Barbagallo, Francesca Ometto, Lee Smith, Shahina Pardhan, Yvonne Barnett, Petre Cristian Ilie, Pınar Soysal, Erik Lagolio, Peter Konstantin Kurotschka, Roberto Tonelli, Jacopo Demurtas
Publikováno v:
International Journal of Infectious Diseases, Vol 103, Iss , Pp 599-606 (2021)
BACKGROUND & AIMS: Hydroxychloroquine (HCQ) and chloroquine (CQ) are anti-malarial drugs frequently used in the rheumatologic field. They were recently identified as potential therapeutic options for Coronavirus Disease (COVID-19). The present study
Externí odkaz:
https://doaj.org/article/bb31488d4f6d4ae5b2aa4e975e3e4e72
Autor:
Nicola Veronese, Jacopo Demurtas, Lin Yang, Roberto Tonelli, Mario Barbagallo, Pierluigi Lopalco, Erik Lagolio, Stefano Celotto, Damiano Pizzol, Liye Zou, Mark A. Tully, Petre Cristian Ilie, Mike Trott, Guillermo F. López-Sánchez, Lee Smith
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
The aim was to investigate the effectiveness of glucocorticoid therapy in patients with COVID-19. A systematic search of the literature across nine databases was conducted from inception until 15th March 2020, following the PRISMA guidelines. Patient
Externí odkaz:
https://doaj.org/article/22ecfaacb977445094afe5987da721c8
Autor:
Francesco Lapi, Alexander Domnich, Ettore Marconi, Alessandro Rossi, Ignazio Grattagliano, Erik Lagolio, Gerardo Medea, Aurelio Sessa, Iacopo Cricelli, Giancarlo Icardi, Claudio Cricelli
Publikováno v:
Expert Review of Vaccines. 21:377-384
General practitioners (GPs) need a valid, user-friendly tool to identify patients most vulnerable to COVID-19, especially in the hypothesis of a booster vaccine dose. The aim of this study was to develop and validate a GP-friendly prognostic index ab
Autor:
Lee Smith, Maria Cristina Polidori, Giorgio M. Cortassa, Thomas Benzing, Cristina Cocino, Stefania Bottone, Jacopo Demurtas, Erik Lagolio, Laura Spadafora, Roberto Buzzetti
Publikováno v:
Internal and Emergency Medicine
There is no univocal standardized strategy to predict outcomes and stratify risk of SARS-CoV-2 infected patients, notably in emergency departments. Our aim is to develop an accurate indicator of adverse outcomes based on a retrospective analysis of a
Autor:
Francesco Lapi, Claudio Cricelli, Ettore Marconi, Alessandro Rossi, Erik Lagolio, Serena Pecchioli, Ercole Concia
Publikováno v:
Journal of Antimicrobial Chemotherapy. 76:2186-2194
Background There are few data comparing the relative effectiveness of the individual β-lactams. Objectives To quantify the reduced effectiveness, defined as switching to a different antibiotic being prescribed for the same indication, among new user
Autor:
Ignazio Grattagliano, Gerardo Medea, Claudio Cricelli, Alessandro Rossi, Nicola Petrosillo, Erik Lagolio, Pierangelo Lora Aprile, Guido Granata, Davide Roberto Donno
Publikováno v:
Infectious Disease Reports
Infectious Disease Reports, Vol 13, Iss 28, Pp 251-258 (2021)
Infectious Disease Reports, Vol 13, Iss 28, Pp 251-258 (2021)
The impact of the coronavirus disease (COVID-19), caused by the novel coronavirus SARS-CoV-2, continues to be widespread, with more than 100 million cases diagnosed in more than 220 countries since the virus was first identified in January 2020. Alth
Publikováno v:
Practical Issues in Geriatrics ISBN: 9783030789220
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9803e8567ae81a0862e89a4538f55a7d
https://doi.org/10.1007/978-3-030-78923-7_14
https://doi.org/10.1007/978-3-030-78923-7_14
Autor:
Jacopo, Demurtas, Roberto, Tonelli, Stefano, Celotto, Nicola, Veronese, Erik, Lagolio, Francesca, Rossi, Enrico, Clini, Elena, Righi, Andreas, Meer
Introduction. The unprecedented covid-19 pandemic has shown the weaknesses of health systems and opened new spaces for e-health and telemedicine. Recent literature states that chatbots, if implemented effectively, could be useful tools for quickly sh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::d2926a6a7719e555e32ea3255f2a5e4f
http://hdl.handle.net/10447/547524
http://hdl.handle.net/10447/547524
Autor:
Lee Smith, Yvonne Barnett, Jacopo Demurtas, Peter Konstantin Kurotschka, Shahina Pardhan, Francesca Ometto, Petre Cristian Ilie, Nicola Veronese, Pinar Soysal, Erik Lagolio, Roberto Tonelli, Mario Barbagallo, Stefano Celotto
Publikováno v:
International Journal of Infectious Diseases
International Journal of Infectious Diseases, Vol 103, Iss, Pp 599-606 (2021)
International Journal of Infectious Diseases, Vol 103, Iss, Pp 599-606 (2021)
Background & aims: Hydroxychloroquine (HCQ) and chloroquine (CQ) are anti-malarial drugs frequently used in the rheumatologic field. They were recently identified as potential therapeutic options for Coronavirus Disease (COVID-19). The present study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd74976fe5bfc148d77cb1d76de39850
https://hdl.handle.net/20.500.12645/37672
https://hdl.handle.net/20.500.12645/37672